Literature DB >> 7689333

Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine.

E S Furfine1, M F Harmon, J E Paith, E P Garvey.   

Abstract

L-NG-Nitroarginine (NA) inhibited both the L-arginine oxidation and the L-arginine-independent NADPH oxidation reactions catalyzed by the calcium/calmodulin-dependent constitutive nitric oxide synthase (cNOS) from bovine brain. NA binding did not require calmodulin, calcium, or NADPH. The onset of inhibition was slow with a second-order association rate constant (k(on) of 4.4 x 10(4) M-1 s-1. The dissociation rate constant (k(off) was 6.5 x 10(-4) s-1. The Kd value (k(off)/k(on)) of bovine brain cNOS for NA was 15 nM. L-Arginine was a competitive inhibitor of NA binding with a Ks value of 0.8 microM. The Km for L-arginine in the cNOS reaction was 1.2 microM. The NA binding sites of cNOS were titrated with NA, which enabled a kcat of 0.7 s-1, for the oxidation of L-arginine, to be calculated. Finally, a brain cNOS-(3H)NA complex was isolated. In contrast to the potent and slow onset of NA inhibition of brain cNOS, NA inhibition of inducible mouse macrophage NOS (iNOS) was weaker (Ki = 4.4 microM) and rapidly reversible. Thus, NA was a 300-fold more potent inhibitor of bovine brain cNOS than mouse macrophage iNOS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689333     DOI: 10.1021/bi00084a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  56 in total

Review 1.  Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion.

Authors:  M D Yago; M Mañas; Z Ember; J Singh
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Neostigmine-induced contraction and nitric oxide-induced relaxation of isolated ileum from STZ diabetic guinea pigs.

Authors:  Joseph Cellini; Anne Marie Zaura Jukic; Kathy J LePard
Journal:  Auton Neurosci       Date:  2011-08-30       Impact factor: 3.145

3.  Structural basis for isoform-selective inhibition in nitric oxide synthase.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Acc Chem Res       Date:  2012-10-02       Impact factor: 22.384

4.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

5.  Decreased contraction induced by endothelium-derived contracting factor in prolonged treatment of rat renal artery with endoplasmic reticulum stress inducer.

Authors:  Makoto Ando; Takayuki Matsumoto; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-04       Impact factor: 3.000

6.  L-NNA inhibits the histochemical NADPH-d reaction in rat spinal cord neurons.

Authors:  D Blottner; H G Baumgarten
Journal:  Histochem Cell Biol       Date:  1995-05       Impact factor: 4.304

7.  Purification and characterization of nitric oxide synthase (NOSNoc) from a Nocardia species.

Authors:  Y Chen; J P Rosazza
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

8.  Contrasting effects of circulating nitric oxide and nitrergic transmission on exocrine pancreatic secretion in rats.

Authors:  E Vaquero; X Molero; V Puig-Diví; J R Malagelada
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 9.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

10.  Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase.

Authors:  M J Miller; J H Thompson; X Liu; S Eloby-Childress; H Sadowska-Krowicka; X J Zhang; D A Clark
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.